ACM
VRTX icon

Argent Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Argent Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,349
Closed -$272K – 189
2021
Q2 		$272K Sell
1,349
-35
-3% -$7.32K 0.01% 177
2021
Q1 		$297K Hold
1,384
– – 0.01% 179
2020
Q4 		$327K Hold
1,384
– – 0.01% 180
2020
Q3 		$377K Hold
1,384
– – 0.01% 183
2020
Q2 		$402K Buy
1,384
+134
+11% +$36.3K 0.02% 177
2020
Q1 		$297K Buy
+1,250
New +$287K 0.01% 191

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argent Capital Management's VRTX Position: Q3 2021 in Review

Argent Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 1,349 shares — an estimated $272K sold.

Argent Capital Management first reported a position in VRTX in Q1 2020 and held it in 6 quarters. The position peaked at $402K in Q2 2020. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

  • Argent Capital Management reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Argent Capital Management sold 1,349 Vertex Pharmaceuticals shares in Q3 2021, an estimated $272K.
  • Argent Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Argent Capital Management's Vertex Pharmaceuticals position peaked at $402K in Q2 2020.
  • 933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Argent Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.